Analytical methods knowledge base
HPLC Peptide Purity: What the Chromatogram Can—and Cannot—Show
A method-aware guide to reversed-phase HPLC area purity, peak integration, system suitability and the limits of turning one chromatographic percentage into a complete quality claim.
Method-aware interpretation
Read the result as a chain of evidence.
Each section connects the analytical question, reporting basis and conclusion boundary.
The result belongs to the method
An HPLC purity value is produced by a defined separation and detection procedure. Column chemistry, gradient, mobile-phase composition, temperature, wavelength, injection load and integration rules influence which components separate and which signals are counted. A percentage without the method and chromatogram is therefore incomplete.
- Confirm the stated detection wavelength and whether all relevant impurities respond at that wavelength.
- Review the gradient, run time and integration threshold rather than comparing percentages from unrelated methods.
- Check whether blank, standard and system-suitability injections are identified.
Area percentage is not a mass balance
Relative peak area describes the distribution of detected chromatographic signal. It does not automatically measure water, counterions, residual solvents, inorganic residue or material that is not detected under the selected conditions. A high main-peak area can coexist with a lower as-is peptide content.
- Do not relabel chromatographic area purity as “peptide content.”
- Do not infer sequence identity from retention time alone.
- Use orthogonal tests when the decision requires identity, composition or absolute content.
System suitability is evidence that the run was capable
Suitability criteria are selected for the intended analytical purpose. Resolution, repeatability, sensitivity, peak symmetry and reference-standard performance may be relevant. Passing a numerical purity specification without demonstrating that the system could resolve and detect the relevant components weakens the interpretation.
- Look for predefined criteria rather than criteria created after the sample result was seen.
- Confirm reference materials are qualified for their role.
- Treat a single exported chromatogram without acquisition context as limited evidence.
Decision table
What the field means—and what it does not prove
Use this table to prevent a valid analytical result from being expanded beyond its intended purpose.
↔ Swipe horizontally to read every column
| Record or question | What it can support | What it does not prove |
|---|---|---|
| Main-peak area reported? | Method-dependent relative chromatographic purity | Identity, mass content or sterility |
| Impurity peaks resolved? | Separation performance for visible components | Absence of undetected or co-eluting components |
| System suitability passed? | The run met predefined performance checks | That the specification itself is appropriate |
Interpretation limits
Stop where the method stops.
- A chromatogram is not a certificate of molecular identity.
- Different HPLC methods are not interchangeable without a justified comparison.
- A catalog statement should identify whether the percentage is area purity, assay or another basis.
Primary and technical sources
Records used for this guide
Sources are linked directly so the wording, date and scope can be checked independently.
- 01Source record
USP General Chapter <621> Chromatography
United States Pharmacopeia. USP–NF General Chapter <621>.
- 02Source record
ICH Q2(R2): Validation of Analytical Procedures
International Council for Harmonisation. Step 4, adopted November 2023; error-corrected 2025.
- 03Source record
Analytical Procedures and Methods Validation for Drugs and Biologics
U.S. Food and Drug Administration. Guidance for Industry, July 2015.
Knowledge center